MRNA · 10-Q · 2026Q2 · Full report

Capital Expenditures

Moderna, Inc. · 2026-07-31 · Importance 41 · Surprise 48

Moderna purchased $99 million of property and equipment during the first six months of 2026. The purchases supported facilities, manufacturing and laboratory equipment, and computer equipment and software. Capital expenditures declined $21 million year over year, contributing to the 80% reduction in net investing cash flow. Future capital requirements include continued investment in manufacturing facilities, laboratory infrastructure, digital capabilities, artificial intelligence technologies, and global commercial infrastructure.